Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Linden Lake Venture Capital is a venture capital firm dedicated to founding, building, and investing in biotechnology companies that develop new molecular medicines. Established with a focus on addressing the needs of patients requiring transformative treatments, the firm combines expertise in biotechnology, medical knowledge, legal acumen, and private equity investment experience. This unique blend of skills positions Linden Lake to make impactful investments in the biotech sector.
The firm has a history of entrepreneurial success, particularly in biotechnology, which enhances its ability to identify and support promising startups. Linden Lake operates with a clear mission to foster innovation in healthcare through strategic investments in early-stage companies. Their current portfolio reflects a commitment to advancing biotechnology solutions that can significantly improve patient outcomes.
Headquartered in the United States, Linden Lake Venture Capital is actively involved in the biotechnology community, collaborating with founders and other stakeholders to drive growth and innovation. The firm has established a reputation for its targeted approach within the biotech sector, focusing on companies that are at the forefront of developing novel therapies.
Linden Lake Venture Capital invests primarily in early-stage biotechnology companies, specifically those engaged in pre-clinical and phase I technologies. Their investment strategy encompasses a range of focus areas, including novel therapeutic biologics, gene/nucleic acid-based therapies, cell/regenerative therapies, and therapeutic modality optimization platforms aimed at personalized medicine.
The firm seeks to identify companies that are pioneering innovative therapeutic modalities, particularly those that can address unmet medical needs. Investments typically occur at the pre-seed, seed, and Series A stages, allowing Linden Lake to support startups from their inception through early development phases. The firm emphasizes the importance of scientific rigor and a strong management team in its investment decisions.
In addition to financial backing, Linden Lake provides strategic guidance and resources to its portfolio companies, leveraging its extensive expertise in biotechnology and healthcare. This approach not only enhances the potential for successful outcomes but also aligns with the firm’s mission to facilitate transformative healthcare solutions.
Linden Lake Venture Capital's portfolio includes notable companies that exemplify its focus on biotechnology innovation:
Thomas Axel Haag, Ph.D., J.D. - Managing Partner. Thomas has extensive experience in biotechnology and venture capital, combining his legal expertise with a deep understanding of the biotech landscape. He has been involved in numerous successful investments and has a strong track record in supporting early-stage companies.
To pitch Linden Lake Venture Capital, founders should utilize the webform available on their website for initial inquiries. It is advisable to include a detailed deck that outlines the startup's technology, market opportunity, and team qualifications.
While specific response time expectations are not provided, founders should be prepared for a thorough review process. Warm introductions may enhance the likelihood of receiving a timely response.
In October 2023, AexeRNA Therapeutics, a portfolio company of Linden Lake Venture Capital, was acquired by BioNTech SE. This acquisition marks a significant milestone for the firm, showcasing its ability to identify and support promising biotechnology companies.
What are Linden Lake's investment criteria?
Linden Lake Venture Capital focuses on early-stage biotechnology companies, particularly those engaged in pre-clinical and phase I technologies. They look for innovative therapeutic modalities and strong management teams capable of executing their vision.
How can founders pitch to Linden Lake?
Founders interested in pitching to Linden Lake should prepare a comprehensive presentation that outlines their technology, market potential, and team qualifications. While specific application forms are not mentioned, a webform on their website can be used for initial inquiries.
What makes Linden Lake different from other investors?
Linden Lake combines deep expertise in biotechnology with legal and private equity knowledge, allowing them to provide not only capital but also strategic guidance to their portfolio companies. This multifaceted approach enhances the potential for successful outcomes in the biotech sector.
What is the geographic scope of Linden Lake's investments?
The firm primarily invests in biotechnology companies based in the United States, although they may consider opportunities in other regions that align with their investment thesis.
What is Linden Lake's follow-on investment behavior?
Linden Lake is known for its commitment to supporting portfolio companies through various stages of development, which may include follow-on investments as companies progress and require additional funding to scale their operations.
What is the typical check size for investments?
While specific check sizes are not disclosed, Linden Lake focuses on early-stage investments, which typically range from pre-seed to Series A funding rounds, indicating a willingness to invest in the initial phases of company development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.